Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Measuring Impact of Pharmaceutical Marketing Via Social Media and Online Video


Published on

Some tips for pharmaceutical marketers interested in the ROI of online-video and social media.

Published in: Business, News & Politics
  • Be the first to comment

Measuring Impact of Pharmaceutical Marketing Via Social Media and Online Video

  1. 1. You visit YouTube when YouTube 101 someone send you a link. But your targets are there and consuming rabidly.   Set up account   Surf most-viewed & most-subscribed   Subscribe to brand/condition terms   Subscribe to Nalts
  2. 2. ROI Via Online Video & SM?
  3. 3. Tri-Polar Guy
  4. 4. Why I Ice Cream
  5. 5. But Viral is Dead pleese god make i viral
  6. 6. ROI Level Setting   It’s “Theoretical” Definition   ratio of money gained or lost on an investment relative to the amount of money invested.   Reality: “new” has burden of proof   Why our Rx Social Media pilots make ROI so damned difficult
  7. 7. Hidden Meaning Behind “ROI”   Are you sure this is worth headache?   Can this effort payoff? “Return” May Translate To…   Business impact (sales, PR, reputation)   Satiating a VP’s desire   An internal win
  8. 8. What We See in Social Media If you’re a marketer… If you’re regulatory/legal
  9. 9. Why We Make ROI So Hard   Not the R   It’s the insane I’s Solution   Guidelines minimize churn   Guerilla cost model   Be sure agency has done it
  10. 10. How to Get Your SM Approved Don’t Call It Social Media Publisher, network or aggregator creates real SM and we, um, advertise. A moderated Facebook site has few legal/reg implication beyond a with “contact us.”
  11. 11. An Impression Isn’t An Impression* *Unless it makes one ☹  In absolute, these can’t matter: ✗  Views ✗  Site visits ✗  Friends ✗  Coupon downloads ✗  Comments ✗  Miss-trials ✗  Buzz ✗  Stupid database ✗  Viral ✗  Industry rags
  12. 12. So What DOES Matter?   Getting their attention   Engaging them   Earning their trust   Answering their questions   Acknowledging needs & concerns   Exciting them about our solution   Inspiring trial (nrx)   Setting their expectations (trx)
  13. 13. Social Score Benchmark   Tools allow brands and companies   Reminder: AEs unlikely to to identify current baseline rock your world (cost,   Frequency of mention people)   Issue alerts   1 in 500, Neilsen 2008   Sentiment (vs competitors)   But we do need to be responsible about trends   Consider patients as family   My two cents is in next Pharmaceutical Executive (How-To Unlock Guidelines)   Surf 117 company policies: http:// policies.php
  14. 14. Myth: Ostrich Option as Safe
  15. 15. Three Low-Hanging-Fruit Tactics a)  Hands-off Social Media b)  Leveraging Star Power c)  Redefining “unbranded”
  16. 16. a) Three Steps to “Hands-Off” SM 1.  Ad network creates and promotes therapeutic- specialty social media in true form. 2.  Brand initiated it, but did not co-sponsor or have role in content 3.  Unbranded rich-media ads drove traffic to product site for very low cost-per-visitor
  17. 17. b) They’re Patients With Reach   You don’t have to know or like them   Video stars > celebrities
  18. 18. b) Engaging Via Video Stars   Leading brands are doing this   Pharma can play too   Fox Broadcasting: 6 million views for pennies per view   MTV salvaged expensive “billboard in back yard” with 6-12% viewers visiting site   Obviously unbranded  branded
  19. 19. Process for Engaging Stars   Creative brief My Own Lil’ Examples:   Draft concepts •  Mentos •  Holiday Inn   Shoot •  MTV •  Starbucks   Approvals •  Logitech •  Fox Broadcasting •  Reader’s Digest   Launch •  Microsoft •  U.S. Census   Provide metrics •  Big Health Co (Friday)
  20. 20. c) Unbranded as Activator   Redefine “unbranded”   2000: Market leaders only   2010: Vital “hook”   Can’t lead with marketing We’ve got to use an unbranded because patients and approach in social media," said Kevin doctors don’t care about Nalty, formerly a product director for Merck, though he now heads Nalts our products at all. Consulting. "There's no way to accommodate what is required of a brand, in terms of fair balance   Captivate, education, information, in a tweet, for example." prompt via unbranded “masked” URL
  21. 21. Conclusion: Metrics Musts   Keep costs down   Open funnel wider by dialing down marketing message   Count only downstream vital signs   Cost per qualified visitor   Cost per new patient   Time & intent   Behavior
  22. 22. Ask Your Doctor About…   (blog)  or  